About
Kaitlin Kestenberg has served as Chief Operating Officer and Senior Vice President, Compliance since April 2024. She joined ADMA in 2012 as a Clinical Research Manager and advanced through positions of increasing responsibility.
Before joining ADMA she held roles in clinical operations, quality operations and compliance at Acorda Therapeutics and Merck & Co. She holds a B.A. from the State University of New York at Albany and an M.S.J. from Seton Hall University.
Roles
Adma Biologics, Inc.
Chief Operating Officer and Senior Vice President, Compliance · Current role
2012–present
ADMA Biologics
Senior Vice President, Compliance & Project Operations
April 2023-March 2024
ADMA Biologics
Vice President, Compliance & Project Management and Acting Head of Analytical and Process Development
May 2021-March 2023
ADMA Biologics
Vice President, Compliance & Project Management
April 2019-May 2021
ADMA Biologics
Senior Director, Compliance, Project Management & Clinical Operations
January 2018-March 2019
Acorda Therapeutics, Inc.
Clinical operations, quality and compliance
—
Merck & Co. Inc.
Clinical operations, quality and compliance
—
Fixed Compensation
FY 2025
All other compensation
$54,284
Performance Compensation
Data from FY 2025
Cash incentive
Non-equity incentive plan (annual bonus)
$359,375
Stock awards
Stock awards (RSUs)
$1,249,989
Also at Adma Biologics, Inc.